glp 1 afib For patients with obesity and atrial fibrillation, GLP-1 receptor agonist drugs may be the weight loss approach that better addresses their arrhythmia, observational data suggested. https://www.medpagetoday.com/cardiology/arrhythmias/120327 Effects of Glucagon-Like Peptide-1 Receptor

Palmer SC, Tendal B, Mustafa RA et al (2021) Sodiumglucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials

The latter has safety and efficacy concerns

By priming dendritic cells and enhancing Th1 and Treg responses, Ta1 could theoretically rebalance the immune dysregulation that drives atopic disease

La deficiencia de vitaminas B puede comprometer la eficiencia metablica, aunque la suplementacin en personas sin deficiencia no ha demostrado acelerar significativamente el metabolismo